Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal RNA processing 12 homolog (RRP12) is a nucleolar RNA-binding protein involved in the maturation and export of eukaryotic ribosomal subunits. Highly conserved, it functions as a key component in ribosome biogenesis, mediating rRNA processing and ribosomal transport. RRP12 is implicated in cell cycle progression, DNA damage response, and apoptosis regulation, primarily through modulating the p53 pathway under stress conditions. Overexpression of RRP12 is associated with proliferation, invasion, and metastasis of various cancer types, including hepatocellular carcinoma and colorectal cancer, and correlates with poor prognosis. Its expression also impacts immune infiltration and checkpoint status in tumors, indicating both biomarker and therapeutic target potential in oncology[1][2][3][4][5].
Modulation of p53-dependent cell death and cell cycle arrest under nucleolar stress or DNA damage; Potential enhancement of chemotherapy-induced nucleolar stress through RRP12 inhibition.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal RNA processing 12 homolog (RRP12).